Cathy Dantzman
6Patents
3h-index
9Co-inventors
42Inventor score
Filing activity: Dec 7, 2001 → Dec 21, 2009
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7256201B2 | Selective estrogen receptor-β ligands | Chemistry; Metallurgy | 12 | Expired |
| US7045539B2 | Therapeutic benzoxazole compounds | Chemistry; Metallurgy | 7 | Expired |
| US7659286B2 | N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide | Human Necessities | 3 | Active |
| US7368461B2 | Compounds and method for the treatment of overactive bladder | Human Necessities | 1 | Expired |
| US7368448B2 | 2-(arylalkoxy)-1-phenylethylamine derivatives as NK1 antagonist and serotonin reuptake inhibitors | Human Necessities | 0 | Expired |
| US7977355B2 | N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.